Neuroendocrine differentiation and hormone-refractory prostate cancer

Prostate

Volumn 28, Issue 3 SUPPL. 6, 1996, Pages 3-8

  Abrahamsson, Per Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

endocrine paracrine; prostate growth; tumor progression

Indexed keywords

BOMBESIN; SEROTONIN; SOMATOSTATIN;

CANCER HORMONE THERAPY; CONFERENCE PAPER; HUMAN; IMMUNOCYTOCHEMISTRY; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 0029947426     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(1996)6+<3::aid-pros2>3.0.co;2-t     Document Type: Conference Paper

References (26)

1. Abrahamsson PA, Wadström LB, Alumets J, Falkmer S, Grimelius L: Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 181:675-683, 1986.
2. di Sant'Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268, 1992.
3. Abrahamsson PA, Wadström LB, Alumets J, Falkmer S, Grimelius L: Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract 182:298-307, 1987.
4. Bonkhoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic and neoplastic human prostate, Prostate 19:91-98, 1991.
5. Abrahamsson PA, Falkmer S, Fält K, Grimelius L: The course of neuroendocrine differentiation in prostatic carcinoma. Pathol Res Pract 185:373-380, 1989.
6. Iwamura M, Wu G, Abrahamsson PA, di Sant'Agnese PA, Cockett ATK, Deftos LJ: Parathyroid hormone-re-lated protein is expressed by prostatic neuroendocrine cells. Urology 43:667-674, 1994.
7. Cecio A, Cocca T, Masotti MT, La Mura E, Vittoria A: CCK-containing paraneurons in human adenomatous prostate. Biosci Rep 13:251-258, 1993.
8. Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch Pathol Anat A 423:291-294, 1993.
9. Iwamura M, di Sant'Agnese PA, Wu G, Benning CM, Cockett ATK, Gershagen S: Overexpression of human epidermal growth factor receptor and c-erbB-2 by neuroendocrine cells in normal prostatic tissue. Urology 43:838-843, 1994.
10. di Sant'Agnese PA, Cockett ATK: The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: A review and future directions in basic research. J Urol 152:1927-1931, 1994.
11. Abrahamsson PA, di Sant'Agnese PA: Neuroendocrine cells in the human prostate gland. J Androl 14:307-309, 1993.
12. Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG: Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 59: 1803-1809, 1987.
13. Turbat-Herrera EA, Turbat-Herrera GA, Lott RL, Grizzle WE, Bonnin JM, Gore I: Neuroendocrine differentiation in prostatic carcinoma. Arch Pathol Lab Med 59:977-982, 1988.
14. Ro JY, Tetu B, Ayala AG, Ordonez NG: Small cell carcinoma of the prostate: Immunohistochemical and electron microscopic studies of 18 cases. Cancer 59:977-982, 1987.
15. Dauge MC, Delmas V: A.P.U.D. type endocrine tumour of the prostate: Incidence and prognosis in association with adenocarcinoma. In Murphy GP, Khoury S, Kuss R, et al. (eds): "Progress in Clinical and Biological Medicine." New York: Alan R Liss, 1986, pp 529-531.
16. Cohen RJ, Glezerson G, Haffeejee Z, Afrika D: Prostatic carcinoma: Histological and immunohistological factors affecting prognosis. Br J Urol 66:405-410, 1990.
17. Glezerson G, Cohen RJ: Prognostic value of neuroendocrine differentiation in prostate cancer. J Urol 145: 296A, 1991.
18. Epstein JI, Weinstein MH, Partin AW: Neuroendocrine differentiation in prostate cancer. Enhanced prediction of progression following radical prostatectomy. J Urol 153:253, 1995.
19. Casamento J, Abrahamsson PA, Nakada SY, di Sant' Agnese PA, de Mesy Jensen K, Cockett ATK: Prognostic significance of neuroendocrine differentiation in prostatic carcinoma. J Urol 147:479, 1992.
20. Noordzij MA, van de Kwast TH, van Steenbrugge GJ, Hop W, Schröder FH: Neuroendocrine cells in radical prostatectomy specimens do not influence prostate cancer progression. J Urol 153:252, 1995.
21. Kadmon D, Thompson TC, Lynch GR, Scardino PT: Elevated plasma chromogranin A concentrations in prostatic carcinoma. J Urol 146:358-361, 1991.
22. Tarle M, Rados N: Investigation on serum neuron-specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assay. Prostate 19:23, 1991.
23. Krijnen JLM, Janssen PJA, Ruizeveld de Winter JA, van Krimpen H, Schröder FH, van der Kwast TH: Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry 100:393-398, 1993.
24. Hoosein NM: Neuropeptides in the progression of prostate cancer. Cancer Bull 45:436-441, 1993.
25. Hoosein NM, Logothetis CJ, Chung LWK: Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 149:1209-1213, 1993.
26. Cockett ATK, di Sant'Agnese PA, Gopinath P, Schoen SR, Abrahamsson PA: Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia. Urology 42:512-519, 1993.